Clinical Trials
We are driven by science and data
We are driven by science and data
Medical research is critical to drive innovation and scientific advancements that can improve patients’ lives – our mission at Ascendis Pharma. Clinical trials are a fundamental step in this process to develop new therapeutics. As a science-based company, we are committed to conducting clinical trials with the utmost quality and respect for both the clinical trial participants and the scientific hypothesis being evaluated.
We have three endocrinology rare disease product candidates — TransCon™ hGH, TransCon PTH and TransCon CNP – in clinical development. In oncology, we are evaluating a portfolio of product candidates.
Explore below for more about our clinical programs.
Trial: ACcomplisH Trial
ACcomplisH: A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Dose Escalation Trial Evaluating the Safety, Efficacy, and Pharmacokinetics of Subcutaneous Doses of TransCon CNP Administered Once Weekly for 12 months in Prepubertal Children with Achondroplasia
Phase: 2
Status: Ongoing
Trial: ACHieve Study
ACHieve: A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia
Phase: Non-interventional (no medication will be given in this study)
Status: Ongoing
We are dedicated to being curious and diligent when innovating, developing and improving products and processes.
Explore
